European Archives - Page 121 of 1659 - European Medical Journal

ICNMD 2026 Interview: Marianne de Visser

Marianne de Visser: Adult Neurologist and Emeritus Professor of Neuromuscular Diseases, Amsterdam University Medical Center…

Johnson & Johnson secures FDA nod for OTTAVA system

J&J receives FDA De Novo authorization for OTTAVA robotic surgical system, launching platform for soft tissue surgery in the US.

Repurposed Drugs Boost Activity Against Resistant Pathogens

Commonly prescribed drugs, including fluoxetine and amlodipine, enhanced antimicrobial activity against multidrug-resistant bacteria and Candida in laboratory tests.

Emerging Challenges in Contemporary Maternity Care: Interview with Karen Joash

The postnatal period remains significantly under-resourced. Women move from receiving intensive support throughout pregnancy to often…

3D Organoid Models Offer New Insight into Motor Neurone Diseases

Human 3D organoid models are shedding new light on the mechanisms underlying motor neuron diseases, researchers have shown.

NHS Approves First Walking Treatment for Multiple Sclerosis

The NHS will offer fampridine to eligible patients with multiple sclerosis in England, providing the first licensed treatment designed to improve walking ability and mobility.

Bladder Cancer Reported in Anti-NXP2 Myositis

The first reported case of bladder carcinoma in anti-NXP2 myositis expands the recognised spectrum of associated malignancies and reinforces the importance of cancer screening in adults with inflammatory myopathy.

Interbed Connectivity Expands Critical Care Surveillance

Repurposed bedside monitors created a centralised critical care surveillance system through interbed connectivity, offering a cost effective model for improving intensive care monitoring.

ESHRE 2026 Interview: Maribel Acién

The role of reproductive surgery has certainly changed. Before IVF became widely available, surgery played a much larger role. Today…

Machine Learning Improved Dialysis Survival Prediction

Machine learning improved survival prediction in elderly dialysis patients by complementing traditional survival analysis. Read more.